MRD
NEWSROOM
NEWSROOM
The Phase II SBIR program advances Medical-Grade Molecular Rebar as a delivery platform for HIV therapy.
MRD is collaborating with researchers at Texas A&M and Texas Biomedical Research Institute.
Source access
The available technical synopsis and publication details are preserved on this page. No separate downloadable file is currently available for this item.

